2016;310(10):R885R895
112 However, in recent years, the FDA has introduced the patient-focused drug development initiative, where patient-reported outcomes such as improvements in quality of life and healthy life years in MASH patients following treatment can serve as trial endpoints, potentially influencing final approval based on these data
However, any spreading, painful, or breathing-related symptoms should prompt urgent care
Round out your wellness with creatine powder, hyaluronic acid powder and digestive enzyme to aid with vitality and post-workout support
Biocare could be used as part of GLP-1-related stomach paralysis treatment (delayed gastric emptying) because it offers prebiotic fibers that promote gut health and gastric motility, the contractions of your stomach muscles that help move food through your digestive tract
For researchers studying melanocortin pharmacology in preclinical models, it remains the reference compound